Search Results 691-700 of 21546 for Inhibition

  1. A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

    About this study. The aim of the trial is to assess the safety and efficacy of the orally-administered, selective complement C5a receptor inhibitor CCX168 ...

  2. Funding - Mayo Clinic Research

    Targeting Drug-Resistant Breast Cancers with Allosteric Cyclin-Dependent Kinase 2 Inhibitors. ... Exploring ACK1 Kinase Inhibition in Triple-Negative Breast ...

  3. Erin W. Meermeier, Ph.D. - Mayo Clinic Faculty Profiles

    Dr. Meermeier uncovers mechanisms of resistance to T-cell-redirected cancer immunotherapy (T-cell-engaging antibodies, checkpoint inhibitors and chimeric ...

  4. Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID) - Mayo Clinic

    Cholinesterase inhibition therapy already initiated. More information. Publications. Publications are currently not available. Additional contact information.

  5. HIV/AIDS - Diagnosis and treatment - Mayo Clinic

    Entry or fusion inhibitors block HIV's entry into CD4 T cells. Examples include enfuvirtide (Fuzeon) and maraviroc (Selzentry). Newer medicines include ...

  6. Lisocabtagene maraleucel (intravenous route) - Side effects & uses - Mayo Clinic

    ... inhibitor, BCL-2 inhibitor) that did not work well. Lisocabtagene maraleucel injection is also used to treat follicular lymphoma (FL) that has come back ...

  7. Sildenafil (oral route) - Side effects & dosage - Mayo Clinic

    Sildenafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. ... If you take sildenafil for pulmonary arterial hypertension, do not ...

  8. A Study to Assess Pre- and Postoperative Serum Mast Cell Tryptase Levels in Primary TKA Patients to Determine Whether There is an Association with the Development of Post-operative Stiffness - Mayo Clinic

    Patients taking mast cell inhibitors and/or degranulation inhibitors for any reason; The presence of infections, highly communicable diseases (e.g. AIDS) ...

  9. Macroglobulinemia Clinical Trials - Mayo Clinic Research

    The scientific hypothesis for use of IMO-8400 to treat patients with Waldenström's macroglobulinemia depends on the inhibition ... inhibitor BGB-11417 in ...

  10. Jim Maher, III, Ph.D. - Mayo Clinic Faculty Profiles

    Examples include studying the tight binding and inhibition of proteins, exploring the ability to trigger new cell responses, enhancing drug delivery, and ...